Congenital generalized lipodystrophy. Report on one case, with special reference to postmortem findings

Area of Science:

• Neuroendocrinology
• Genetics
• Pediatric Pathology

Background:

• Generalized lipodystrophy, also known as Berardinelli-Seip's syndrome, is a rare genetic disorder characterized by a near-complete absence of adipose tissue.
• The syndrome presents with a complex array of metabolic abnormalities, including insulin resistance, hypertriglyceridemia, and hepatic steatosis.
• The precise pathophysiological mechanisms underlying generalized lipodystrophy remain incompletely understood, particularly concerning central nervous system involvement.

Observation:

• A case study of a male infant diagnosed with generalized lipodystrophy at 8.5 months of age is presented.
• The patient experienced a fatal outcome at 19 months due to aspiration of food.
• Post-mortem examination focused on the central nervous system (CNS).

Findings:

• Necropsy revealed hypothalamic lesions in the affected infant.
• These hypothalamic abnormalities were characterized as likely malformative or hamartomatous in origin.
• The presence of hypothalamic lesions provides a potential anatomical basis for the observed clinical manifestations.

Implications:

• The findings suggest a critical role for hypothalamic dysfunction in the pathogenesis of generalized lipodystrophy.
• This supports the hypothesis that central regulatory mechanisms, mediated by the hypothalamus, are integral to adipose tissue homeostasis.
• Further research into hypothalamic-CNS interactions may reveal novel therapeutic targets for managing Berardinelli-Seip's syndrome and related metabolic disorders.